Antibodies

Israeli startup to use AI to transform antibody discovery, design

"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.

 AI (Artificial Intelligence) letters and robot hand miniature in this illustration taken, June 23, 2023.
 (l-r) Ariel Tennenhouse, Lev Khmelnitsky, Prof. Sarel Fleishman, Razi Khalaila

Researchers find new way to make animal antibodies safe for humans

 A highly contagious viral disease. Influenza virus

Flu viruses may be combated with new antibody, study finds

ADULTS SHOULD aim for seven to nine hours, and older adults should aim for seven to eight hours.

Sleeping less than six hours will decrease vaccine effectiveness - study


COVID-19: Loss of taste, smell? It may actually be a good thing - study

Olfactory loss typically appears early in the onset of COVID-19 and at times could be the sole indicator that an individual is actually sick, as 20% of patients may have no other symptoms.

 Anosmia or smell blindness, loss of the ability to smell, one of the possible symptoms of COVID-19.

Omicron subvariants getting better at evading antibodies

Scientists have been increasingly focusing on the BA.2.75.2, BF.7 (also known as BA.5.2.1.7) and BQ.1.1 variants in recent weeks.

 Shaare Zedek hospital team members wearing safety gear as they work in the Coronavirus ward of Shaare Zedek hospital in Jerusalem on February 09, 2022.

COVID: Omicron BA.2 infection after vaccine can protect from BA.4/BA.5 - study

Breakthrough infections of COVID-19 Omicron BA.2 in people who have received the Pfizer/BioNTech vaccine have more antibodies against the dominant BA.4/BA.5 descendants.

 Coronavirus cells (illustrative)

New HIV vaccine can produce strong antibodies - study

The study notes the obstacle to creating a vaccine that can induce strong antibodies that can neutralize HIV strains.

3D print of HIV surface protein gp120. An antibody also is attached at the top (green and blue). When antibodies stick to viruses, they may prevent or limit infection of host cells.

Scientists find COVID-19 antibodies that can make boosters unnecessary

Researchers at Tel Aviv University found two antibodies that neutralize all known strains of COVID-19 with up to 95% efficiency.

 The COVID-19 vaccine (illustrative).

Deauthorized COVID-19 treatments still administered in 2022 - study

Researchers discovered that in early 2022, hospitals administered 158,000 doses of unauthorized monoclonal antibody treatments.

A vial of Regeneron monoclonal antibody sits on a medical table as registered nurse Jessica Krumwiede attempts to find a vein to administer it to Cathy Hardin, who was vaccinated prior to testing positive for the coronavirus disease (COVID-19), at the Sarasota Memorial Urgent Care Center in Sarasota

This antibody may protect against COVID-19 and all its variants - study

The antibody in question was easily induced in rhesus macaque monkeys and provided broad protection against not just COVID-19 and variants but other SARS viruses.

 COVID-19 (illustrative)

COVID-19: Blood cancer patients gain antibodies from vaccine booster - study

Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.

An undated transmission electron micrograph of SARS-CoV-2 virus particles, also known as novel coronavirus, the virus which causes COVID-19, isolated from a patient.

New rapid test measures immunity to COVID-19

The study, conducted at Mount Sinai, is one of the first to successfully measure T cell responses, which may be able to ensure protection after antibodies are gone.

3D print of HIV surface protein gp120. An antibody also is attached at the top (green and blue). When antibodies stick to viruses, they may prevent or limit infection of host cells.

Israeli researchers find a new, natural weapon for fighting cancer

Natural antibodies found in tumors could point the way toward improved immunotherapy, according to a new Weizmann Institute study, a potential cancer breakthrough.

 Scan photos of a tumor; in it you can see cancerous cells that are colored in purple.

Children infected by COVID continue to have antibodies - How protected are they?

Study shows that children infected with COVID-19 continue to have antibodies at least six months afterwards, but protection against Omicron still unclear.

 Coronavirus cells (illustrative)